Crenezumab for Prodromal to Mild Alzheimer's Disease

Language Undefined Purpose: To test the experimental drug crenezumab in people with early to mild Alzheimer's disease.  
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: Source Type: clinical trials